| Patient | Robert Peary |
|---|---|
| Date of birth | 1856-05-06 |
| Identifiers | MRN HR-EX004-SYN-TD; SSN (made up) 000-04-7351 |
| Document date | 1919-03-10 |
| Author | Thaddeus Lindgren-Okafor, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Eight-week review: blood count, methylmalonic acid, iron studies and the biopsy results. [S]
Admiral Peary returns eight weeks after starting treatment. He feels close to his old self, walks a mile with his stick and has no breathlessness. The tingling has mostly gone, but the ends of his feet remain numb and he is still unsteady in the dark. He has given himself all his weekly injections. He has had no falls and no new foot wounds. The biopsies from his endoscopy show autoimmune atrophic gastritis: atrophy of the body of the stomach with intestinal metaplasia and enterochromaffin-like cell hyperplasia, a normal antrum, no Helicobacter pylori on special stains, and no neuroendocrine tumor or dysplasia. He has no indigestion and no black stools. [S]
| Element | Detail |
|---|---|
| Hemoglobin | 14.1 g/dL; MCV 91 fL |
| Response markers | Methylmalonic acid 0.26 µmol/L; homocysteine 11 |
| Iron | Ferritin 24 ng/mL; transferrin saturation 14% |
| Biopsies | Autoimmune atrophic gastritis; no neuroendocrine tumor or dysplasia |
| Feet | Numbness at the ends persists; no wounds; no falls |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy back to near normal |
| Gastrointestinal | Negative | No indigestion, black stools or weight loss |
| Neurological | Positive | Numbness at the ends of the feet; unsteady in the dark |
| Psychiatric | Negative | Mood good |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Cyanocobalamin (vitamin B12) 1,000 micrograms (1 mg/mL) intramuscular injection every other day for seven doses, given by the clinic nurse after the intake blood tests were drawn | 1,000 micrograms into the muscle every other day, seven doses | Intramuscular route | 1919-01-13 to 1919-01-25 | completed | S |
| Cyanocobalamin (vitamin B12) 1,000 micrograms (1 mg/mL) intramuscular injection once a week while the nerves recover | 1,000 micrograms into the muscle once a week, self-injected after teaching | Intramuscular route | 1919-02-01 to 1919-04-26 | completed | S |
| Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet every other day on an empty stomach with a glass of orange juice | One tablet every other day, apart from tea and coffee, for three months after the ferritin is normal | Oral route | 1919-03-10 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1919-03-10 | Body height | 183 | cm | S |
| 1919-03-10 | Body weight | 74 | kg | S |
| 1919-03-10 | Body mass index (BMI) [Ratio] | 22.1 | kg/m2 | S |
| 1919-03-10 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1919-03-10 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 1919-03-10 | Heart rate | 74 | /min | S |
| 1919-03-10 | Respiratory rate | 14 | /min | S |
| 1919-03-10 | Body temperature | 36.6 | Cel | S |
| 1919-03-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1919-03-10 | Hemoglobin [Mass/volume] in Blood | 14.1 | g/dL | 13.2-17.1 g/dL | Normal | S |
| 1919-03-10 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 91 | fL | 80-100 fL | Normal | S |
| 1919-03-10 | Erythrocyte [DistWidth] in Blood by Automated count | 15.6 | % | 11-15% | High | S |
| 1919-03-10 | Leukocytes [#/volume] in Blood by Automated count | 6.2 | 10*3/uL | 3.8-10.8 10*3/uL | Normal | S |
| 1919-03-10 | Platelets [#/volume] in Blood by Automated count | 248 | 10*3/uL | 140-400 10*3/uL | Normal | S |
| 1919-03-10 | Methylmalonate [Moles/volume] in Serum or Plasma | 0.26 | umol/L | <=0.4 umol/L | Normal | S |
| 1919-03-10 | Homocysteine [Moles/volume] in Serum or Plasma | 11 | umol/L | <=15 umol/L | Normal | S |
| 1919-03-10 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma | 190 | U/L | 120-250 U/L | Normal | S |
| 1919-03-10 | Bilirubin.total [Mass/volume] in Serum or Plasma | 0.7 | mg/dL | 0.2-1.2 mg/dL | Normal | S |
| 1919-03-10 | Ferritin [Mass/volume] in Serum or Plasma | 24 | ng/mL | 30-400 ng/mL | Low | S |
| 1919-03-10 | Iron [Mass/volume] in Serum or Plasma | 52 | ug/dL | 50-180 ug/dL | Normal | S |
| 1919-03-10 | Iron binding capacity [Mass/volume] in Serum or Plasma | 382 | ug/dL | 250-425 ug/dL | Normal | S |
| 1919-03-10 | Iron saturation [Mass Fraction] in Serum or Plasma | 14 | % | 20-50% | Low | S |
Vital signs recorded on 1919-03-10; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Good color; blood pressure 128/74, pulse 74 |
| Neurological | Vibration reduced but present at the ankles; joint position sense normal; ankle jerks absent; Romberg sway without falling; Timed Up and Go 11 seconds |
| Feet | Skin intact; small callus under the right first metatarsal head; monofilament felt at 6 of 10 sites on each forefoot |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Fatigue, breathlessness on exertion, pallor with a lemon-yellow tinge, a sore tongue, and numbness and unsteadiness in the feet over about four months, with a macrocytic anemia, low white cells and platelets, a low vitamin B12 and a high methylmalonic acid; cause under evaluation with a hematology consultation | resolved | confirmed | D51.9 | S — Synthetic presenting problem anchored to the documented pernicious anemia of his last years; superseded when the consultation confirmed pernicious anemia. |
| Pernicious anemia (autoimmune gastritis with intrinsic factor antibodies), with severe vitamin B12 deficiency; synthetic modern diagnosis linked to the documented cause of his death | active | confirmed | D51.0 | S — Synthetic modern diagnosis made at the consultation, anchored to his documented death from pernicious anemia; the timing and course in the modern episode are synthetic. |
| Subacute combined degeneration of the spinal cord with peripheral neuropathy from vitamin B12 deficiency: loss of vibration and joint position sense in the feet, absent ankle jerks, brisk knee jerks and a positive Romberg test | active | confirmed | G32.0 | S — Synthetic neurological complication; not a claim about his real nerves. |
| Absence of the second to fifth toes of the right foot after frostbite and amputation in early middle age; healed stumps; callus under the first metatarsal head | active | confirmed | Z89.421 | S — Synthetic modern coding of his documented toe amputations; the count of toes is synthetic (CLM-0007). |
| Absence of the second to fifth toes of the left foot after frostbite and amputation in early middle age; healed stumps | active | confirmed | Z89.422 | S — Synthetic modern coding of his documented toe amputations; the count of toes is synthetic (CLM-0007). |
| One fall in a dark bedroom a month ago without injury; unsteady in the dark and on uneven ground; uses a stick outdoors | active | confirmed | Z91.81 | S — Synthetic fall linked to the neuropathy and the old toe amputations. |
| Autoimmune atrophic gastritis, corpus-predominant, with intestinal metaplasia and enterochromaffin-like cell hyperplasia in the body of the stomach, a spared antrum, no Helicobacter pylori, no neuroendocrine tumor and no dysplasia | active | confirmed | K29.40 | S — Synthetic endoscopy and pathology result, the cause of the pernicious anemia; not a claim about his real stomach. |
| Iron deficiency without anemia, unmasked by the recovery of red cell production and the poor iron absorption of atrophic gastritis; colonoscopy and endoscopy without a bleeding source | active | confirmed | E61.1 | S — Synthetic finding at eight weeks. |
| Blister on the end of the left forefoot over the old amputation stump, from boots not yet broken in, in a foot with reduced sensation; no infection; healed in two weeks | resolved | confirmed | S90.822A | S — Synthetic acute foot problem; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Symptoms: fatigue, breathlessness, exercise tolerance, sore tongue, numbness | Every visit during active treatment | Completed today | No fatigue or breathlessness; numbness at the ends of the feet |
| Laboratory | Blood count with MCV | About eight weeks after starting replacement, with earlier checks in severe anemia | Completed today | Hemoglobin 14.1 g/dL, MCV 91 fL, RDW 15.6%, white cells 6.2, platelets 248: normalized |
| Laboratory | Methylmalonic acid and homocysteine | One week to three months after starting replacement | Completed today | Methylmalonic acid 0.26 µmol/L and homocysteine 11 µmol/L, normal; LDH 190 U/L and bilirubin 0.7 mg/dL, normal |
| Laboratory | Serum vitamin B12 | Not routinely after replacement starts | Not indicated | Not rechecked once treatment is established |
| Laboratory | Iron studies (ferritin, transferrin saturation) | When the blood count recovers, and about three months into oral iron | Completed today | Ferritin 24 ng/mL, iron 52 µg/dL, TIBC 382 µg/dL, saturation 14%: iron deficiency; oral iron started |
| Medication safety | Injection plan: doses given, self-injection technique, site problems | Every visit | Completed today | All weekly self-injections given |
| Examination | Neurological examination: vibration, joint position, reflexes, Romberg, gait, cognition | At diagnosis and at follow-up visits for six weeks to three months, then until recovery levels off | Completed today | Vibration returning at the ankles; Romberg sway; ankle jerks still absent |
| Examination | Falls and gait: falls since the last visit, Timed Up and Go, home hazards | Every visit | Completed today | No falls; Timed Up and Go 11 seconds |
| Examination | Upper endoscopy with Sydney-protocol biopsies for autoimmune gastritis, neuroendocrine tumors and dysplasia | At diagnosis of pernicious anemia; then by individual risk | Completed today | Biopsies: autoimmune atrophic gastritis with intestinal metaplasia and enterochromaffin-like cell hyperplasia; no Helicobacter pylori, neuroendocrine tumor or dysplasia; surveillance every three years by shared decision |
| Laboratory | Autoimmune screening: TSH and thyroid antibodies; HbA1c | At diagnosis, then TSH yearly | Up to date | TSH 2.6, thyroid antibody negative and HbA1c 5.5% at diagnosis; TSH due in a year |
| Self-management | Feet: daily skin checks, footwear, callus and stump skin, monofilament | Every visit | Completed today | Skin intact; monofilament felt at 6 of 10 sites on each forefoot |
| Referral | Physical therapy for balance and gait | From diagnosis until balance recovers | Completed today | Twice a week; home program |
Goal progress:
Guideline basis: Guidelines for the diagnosis and treatment of cobalamin and folate disorders (2014); Vitamin B12 deficiency in over 16s: diagnosis and management (NG239) (2024); AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021); CMID: Clinical Monitoring Intelligence Database, anemia and depression, bipolar, and mood disorders monographs (2026); Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update) (2023); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024)
Follow-up: Preventive visit in two weeks. Fifteen-week review with the blood count and iron studies. Continue weekly injections. Next scheduled visit 1919-03-24: periodic adult preventive visit. [S]